If We Pull the Plug on Drug Rebates, Can We Finally Focus on Value?

Posted by Pratap Khedkar on Thu, Oct 18, 2018

 

As more healthcare stakeholders clamor for price transparency, prescription drug rebates’ days could be numbered. Whether the behind-the-scenes negotiation tool—which has been linked to a growing discrepancy between a drug’s list and net prices—will partially or completely disappear is up for debate, but one certainty at this point is that the price transparency knock rarely goes unanswered.


>
Read More

Has Gawande Found the Right Man for the Job?

Posted by Pratap Khedkar on Thu, Sep 20, 2018

Paul Darling co-authored this blog post with Pratap Khedkar.

What kind of skills will it take to run the day-to-day operations for a potentially paradigm-shifting undertaking in U.S. healthcare delivery? It turns out that it's hands-on experience helping patients navigate the complexities of healthcare options and helping employers control healthcare costs, powered by an undercurrent of digital health expertise.


>
Read More

Trump’s Drug Pricing Plan: What Does it Really Mean for Pharma?

Posted by Pratap Khedkar on Wed, Jul 04, 2018

Howard Deutsch co-authored this blog post with Pratap Khedkar.

President Donald Trump and HHS Secretary Alex Azar addressed the nation from the White House Rose Garden last week, introducing American Patients First, a drug pricing plan that Pres. Trump described as the “most sweeping action in history to lower the price of prescription drugs.” Let’s take a closer look, shall we?


>
Read More

Bezos, Buffet and Dimon Bring in Part-Time CEO Gawande: Who Will Be the Muscle?

Posted by Paul Darling on Mon, Jun 25, 2018

Pratap Khedkar co-wrote this blog post with Paul Darling.

Boston-based Atul Gawande needs a new name plate as he adds CEO to an already long list of titles including surgeon, professor, writer and executive director. Gawande is a crusader who’s focused on improving healthcare delivery and accessibility, so company leaders Jeff Bezos, Warren Buffett and Jamie Dimon are confident that Gawande’s background and passion make him the ideal ambassador to advocate for and deliver a revamped healthcare experience for their collective employees in their joint healthcare entity, which we like to call “BerkshAmazMorgan.” For Gawande, this chief executive post likely is an appealing opportunity to experiment with an entirely new care delivery paradigm that one day could be applied outside these corporations’ walls.


>
Read More

Achieve KAM Success by Overcoming the ‘Challenge From Within’

Posted by Pratap Khedkar on Wed, May 09, 2018

Headlines proclaiming the latest healthcare merger, consolidation or vertical integration are hitting our screens with increasing frequency. The U.S. healthcare ecosystem is changing pretty rapidly now. Care delivery models are shifting, and cross-industry collaborations are more commonplace.


>
Read More